{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-027756","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.843938+00:00","generated_at":"2026-05-15T12:43:06.301344+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"60 Degrees Pharmaceuticals files updated legal opinion for ATM program","bullets":["Filed updated legal opinion of Sichenzia Ross Ference Carmel LLP regarding shares sold under ATM Program.","Opinion confirms validity of shares sold under Sales Agreement dated September 5, 2025 with HC Wainwright & Co.","No changes to the terms of the ATM Program; opinion is procedural for ongoing offerings."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-027756","json":"https://secwatch.observer/filing/0001213900-26-027756.json","markdown":"https://secwatch.observer/filing/0001213900-26-027756.md","text":"https://secwatch.observer/filing/0001213900-26-027756.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026027756/0001213900-26-027756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026027756/ea0281691-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:43:06.301344+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}